Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels

Journal of Physiology

Volumn 553, Issue 3, 2003, Pages 789-802

  Lechner, Stefan G ^a   Mayer, Martina ^a   Boehm, Stefan ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MECAMYLAMINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; OXOTREMORINE; PERTUSSIS TOXIN; PIRENZEPINE; POTASSIUM CHANNEL; POTASSIUM ION; RECEPTOR SUBTYPE; RETIGABINE; TRITIUM; CARBAMIC ACID DERIVATIVE; DRUG DERIVATIVE; OXOTREMORINE M; PHENYLENEDIAMINE DERIVATIVE; TETRODOTOXIN; VOLTAGE GATED POTASSIUM CHANNEL; CALCIUM ION; M TYPE POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CERVICAL GANGLION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPOLARIZATION; HYPERPOLARIZATION; ION CURRENT; MEMBRANE POTENTIAL; NERVE CELL STIMULATION; NEUROTRANSMITTER RELEASE; NEWBORN; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE CELL; ANIMAL; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EVOKED RESPONSE; NERVE CELL; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT; SUPERIOR CERVICAL GANGLION; CALCIUM CELL LEVEL; CELLULAR SECRETION; CONCENTRATION RESPONSE; DRUG INHIBITION; INTRACELLULAR SIGNALING; NERVE CELL CULTURE; NERVE CELL MEMBRANE STEADY POTENTIAL; POTASSIUM CURRENT; PROTEIN INTERACTION;

ANIMALS; ANIMALS, NEWBORN; CARBAMATES; CELLS, CULTURED; EVOKED POTENTIALS; MECAMYLAMINE; MEMBRANE POTENTIALS; MUSCARINIC AGONISTS; NEURONS; NOREPINEPHRINE; OXOTREMORINE; PERTUSSIS TOXIN; PHENYLENEDIAMINES; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M1; SUPERIOR CERVICAL GANGLION; TETRODOTOXIN;

EID: 0345767119     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.052449     Document Type: Article

References (43)

1. Arunlakshana O & Schild HO (1959). Some quantitative uses of drug antagonists. Br J Pharmacol 14, 48-58.
2. 2+ current and M current in rat sympathetic neurons. Proc Natl Acad Sci U S A 89, 9544-9548.
3. Bhave SV, Malhotra RK, Wakade TD & Wakade AR (1988). Formation of inositol trisphosphate by muscarinic agents does not stimulate transmitter release in cultured sympathetic neurons. Neurosci Lett 90, 234-238.
4. Boehm S (1998). Selective inhibition of M-type potassium channels in rat sympathetic neurons by uridine nucleotide preferring receptors. Br J Pharmacol 124, 1261-1269.
5. Boehm S (1999). ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci 19, 737-746.
6. 2+ channels. Neuroscience 69, 221-231.
7. 2-autoreceptors control sympathetic transmitter release. Eur J Neurosci 8, 1924-1931.
8. Boehm S & Huck S (1997). Receptors controlling transmitter release from sympathetic neurons in vitro. Prog Neurobiol 51, 225-242.
9. Boehm S & Kubista H (2002). Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54, 43-99.
10. Bofill-Cardona E, Vartian N, Nanoff C, Freissmuth M & Boehm S (2000). Two different signaling mechanisms involved in the excitation of rat sympathetic neurons by uridine nucleotides. Mol Pharmacol 57, 1165-1172.
11. Brown AM (1967). Cardiac sympathetic adrenergic pathways in which synaptic transmission is blocked by atropine sulphate. J Physiol 191, 271-288.
12. Brown DA (1983). Slow cholinergic excitation - a mechanism for increasing neuronal excitability. Trends Neurosci 6, 302-307.
13. Caulfield MP (1993). Muscarinic receptors - characterization, coupling and function. Pharmacol Ther 58, 319-379.
14. Caulfield MP & Birdsall NJ (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50, 279-290.
15. Cunnane TC & Searl TJ (1994). Neurotransmittcr release mechanisms in autonomic nerve terminals. Molecular and Cellular Mechanisms of Neurotransmitter Release, ed. Stjärne L, Greengard P, Grilner S, Hökfelt T & Ottoson D, pp. 425-4459. Raven Press Ltd, New York.
16. 2+ mobilization in rat sympathetic neurons, but this signalling pathway does not mediate M-current inhibition. J Physiol 520, 101-111.
17. 2-adrenoceptors inhibit calcium influx in terminals of chicken sympathetic neurons and noradrenaline release evoked by nicotinic stimulation. Neurosci Lett 180, 63-66.
18. Eglen RM, Choppin A & Watson N (2001). Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 22, 409-414.
19. Feldberg W & Gaddum JH (1934). The chemical transmitter at synapses in a sympathetic ganglion. J Physiol 81, 305-319.
20. Göbel I, Trendelenburg AU, Cox SL, Meyer A & Starke K (2000). Electrically evoked release of [(3)H] noradrenaline from mouse cultured sympathetic neurons, release-modulating heteroreceptors. J Neurochem 75, 2087-2094.
21. Greene LA & Rein G (1978). Release of norepinephrine from neurons in dissociated cell cultures of chick sympathetic ganglia via stimulation of nicotinic and muscarinic acetylcholine receptors. J Neurochem 30, 579-586.
22. q contributes to muscarinic inhibition of the M-type potassium current in sympathetic neurons. J Neurosci 18, 4521-4531.
23. Koh DS & Hille B (1997). Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry. Proc Natl Acad Sci U S A 94, 1506-5611.
24. Kristufek D, Koth G, Motejlek A, Schwarz K, Huck S & Boehm S (1999). Modulation of spontaneous and stimulation-evoked transmitter release from rat sympathetic neurons by the cognition enhancer linopirdine, insights into its mechanisms of action. J Neurochem 72, 2083-2091.
25. Lindmar R, Loffelholz K & Muscholl E (1968). A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents. Br J Pharmacol 32, 280-294.
26. Liu L & Rittenhouse AR (2003). Pharmacological discrimination between muscarinic receptor signal transduction cascades with bethanechol chloride. Br J Pharmacol 138, 1259-1270.
27. Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ & Burbidge SA (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 58, 253-262.
28. Marrion NV (1997). Control of M-current. Annu Rev Physiol 59, 483-504.
29. 1-subtype. Br J Pharmacol 98, 557-573.
30. Norenberg W, Gobel I, Meyer A, Cox SL, Starke K & Trendelenburg AU (2001). Stimulation of mouse cultured sympathetic neurons by uracil but not adenine nucleotides. Neuroscience 103, 227-236.
31. + currents in rat cultured thoracolumbar sympathetic neurones and their role in uracil nucleotide-evoked noradrenaline release. Br J Pharmacol 129, 709-723.
32. Olianas MC, Maullu C, Adem A, Mulugeta E, Karlsson E & Onali P (2000). Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7). Br J Pharmacol 131, 447-452.
33. Rae J, Cooper K, Gates P & Watsky M (1991). Low access resistance perforated patch recordings using amphotericin B. J Neurosci Meth 37, 15-26.
34. Reitstetter R, He DS & Gruener R (1994). Oxotremorine-M activates single nicotinic acetylcholine receptor channels in cultured Xenopus myocytes. Eur J Pharmacol 264, 27-32.
35. 3H] norepinephrine release by activation of α-2 adrenergic receptors in cultured rat ganglion cells. Neuroscience 52, 107-113.
36. + channel activity in sympathetic neurons. Life Sci 68, 2481-2487.
37. Suh BC & Hille B (2002). Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35, 507-520.
38. Tatulian L & Brown DA (2003). Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J Physiol 549, 57-63.
39. Tatulian L, Delmas P, Abogadie FC & Brown DA (2001). Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci 21, 5535-5545.
40. 4-receptor-deficient mice. Br J Pharmacol 138, 469-480.
41. Trendelenburg U (1966). Transmission of preganglionic impulses through the muscarinic receptors of the superior cervical ganglion of the cat. J Pharmacol Exp Ther 154, 426-440.
42. Wickenden AD, Yu W, Zou A, Jegla T & Wagoner PK (2000). Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 58, 591-600.
43. Xian H, Coggan JS, Knoper SR & Kreulen DL (1994). The muscarinic receptor agonist oxotremorine methiodide evokes a nicotinic response in mammalian sympathetic neurons. Eur J Pharmacol 259, 21-25.